Intranasal delivery of peptide-modified quercetin liposomes suppresses neuroinflammation

Key Points

• Neuroinflammation significantly decreased with peptide-modified quercetin liposomes, indicating a promising intervention.
• The study found a 40% reduction in inflammatory markers following intranasal delivery of the liposomes.
• Analysis utilized intranasal delivery methods in a preclinical model to evaluate the effect on neuroinflammation.
• This suggests potential for developing targeted therapies, requiring further investigation in human subjects.